Endogenous and exogenous vasopressin during hemodialysis

Seminars in Dialysis

Volumn 22, Issue 5, 2009, Pages 472-475

  Thompson, Aliza M ^b   Oliver, Juan A ^a  

^a Columbia University ^*  (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN DERIVATIVE;

ARTICLE; HUMAN; HYPOTENSION; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

HUMANS; HYPOTENSION; RENAL DIALYSIS; VASOPRESSINS;

EID: 70350011825     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00615.x     Document Type: Article

References (31)

1. Shoji T, Tsubakihara Y, Fujii M, Imai E : Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66 : 1212 1220, 2004
2. Henrich WL : Hemodynamic instability during hemodialysis. Kidney Int 30 : 605 612, 1986
3. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW : Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 47 : 830 841, 2006
4. Charra B, Calemard M, Laurent G : Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16 : 35 44, 1996
5. Schreiber Jr. MJ : Setting the stage. Am J Kidney Dis 38 (4 Suppl. 4 S1 S10, 2001
6. Converse Jr. RL, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG : Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 90 : 1657 1665, 1992
7. Baldamus CA, Ernst W, Frei U, Koch KM : Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 31 : 324 332, 1982
8. Kooman JP, Gladziwa U, Bocker G, van Bortel LM, van Hooff JP, Leunissen KM : Role of the venous system in hemodynamics during ultrafiltration and bicarbonate dialysis. Kidney Int 42 : 718 726, 1992
9. Hegbrant J, Thysell H, Martensson L, Ekman R, Boberg U : Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis. Nephron 63 : 303 308, 1993 (Pubitemid 23082072)
10. Fasanella d'Amore T, Wauters JP, Waeber B, Nussberger J, Brunner HR : Response of plasma vasopressin to changes in extracellular volume andor plasma osmolality in patients on maintenance hemodialysis. Clin Nephrol 23 : 299 302, 1985
11. Horky K, Sramkova J, Lachmanova J, Tomasek R, Dvorakova J : Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 11 : 241 246, 1979
12. Os I, Nordby G, Lyngdal PT, Eide I : Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration. Scand J Urol Nephrol 27 : 93 99, 1993
13. Holmes CL, Landry DW, Granton JT : Science review: vasopressin and the cardiovascular system part 1 - receptor physiology. Crit Care 7 : 427 434, 2003
14. Oliver G, Schafer EA : On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication. J Physiol 18 : 277 279, 1895
15. Braunwalde E, Wagner HN : The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 35 : 1412 1418, 1956
16. Dunn FL, Brennan TJ, Nelson AE, Robertson GL : The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 52 : 3212 3219, 1973
17. Robertson GL, Athar S : The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 42 : 613 620, 1976
18. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC : Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 : 973 980, 1998
19. Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW : Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 28 : 249 252, 2000 (Pubitemid 30091063)
20. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA : Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 : 1122 1125, 1997 (Pubitemid 27097820)
21. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H : Role of vasopressin in essential hypertension: racial differences. J Hypertens 15 : 545 550, 1997
22. Gavras H, Ribeiro AB, Kohlmann O, Saragoa M, Mulinari RA, Ramos O, Gavras I : Effects of a specific inhibitor of the vascular action of vasopressin in humans. Hypertension 6 (2 Pt 2 I156 I160, 1984
23. Aisenbrey GA, Handelman WA, Arnold P, Manning M, Schrier RW : Vascular effects of arginine vasopressin during fluid deprivation in the rat. J Clin Invest 67 : 961 968, 1981
24. Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G : V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci U S A 103 : 7807 7812, 2006
25. Henrich WL, Woodard TD, Blachley JD, Gomez-Sanchez C, Pettinger W, Cronin RE : Role of osmolality in blood pressure stability after dialysis and ultrafiltration. Kidney Int 18 : 480 488, 1980
26. Henrich WL, Woodard TD, McPhaul Jr. JJ : The chronic efficacy and safety of high sodium dialysate: double-blind, crossover study. Am J Kidney Dis 2 : 349 353, 1982
27. Van Stone JC, Bauer J, Carey J : The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 2 : 58 64, 1982
28. Rosansky SJ, Rhinehart R, Shade R : Effect of osmolar changes on plasma arginine vasopressin (PAVP) in dialysis patients. Clin Nephrol 35 : 158 164, 1991
29. Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J, Goode D : Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension. Am J Nephrol 10 : 269 275, 1990
30. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG : Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115 : 291 297, 2003
31. van der Zee S, Thompson A, Zimmerman R, Lin J, Huan Y, Braskett M, Sciacca RR, Landry DW, Oliver JA : Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int 71 : 318 324, 2007